Ecoeos develops clinically-validated DNA tests to measure personal susceptibility to environmental toxins.
More than 250 companies have been started by UW students and faculty or with UW technology
Ennaid Therapeutics is a pharmaceutical company rooted in Infectious Diseases. It is focused on developing drugs for dengue fever and West Nile virus.
EpiThany is a clinical-stage biotechnology company developing therapeutic vaccines for a variety of solid tumors.
Erudite developed a novel type of acoustical sensor that, when installed in a container, can detect whether it has been opened or its contents tampered with en route. The company had also created a GPS lock that can both track a container's whereabouts and prevent it from being opened until it reaches its intended destination.
Fate Therapeutics is a clinical‑stage biopharmaceutical company engaged in the development of programmed cellular therapeutics for the treatment of severe, life‑threatening diseases.
GenetikSignal provides novel screening methods for discovering anti-aging drugs.
Greenroads Foundation is a sustainability rating system for roadway design and construction projects. It awards points for more sustainable design and construction practices on roadway projects.
Healionics created what is now known as STAR® (Sphere Templated Angiogenic Regeneration) biomaterial, a precision-engineered three-dimensional biomaterial scaffold that is designed to heal around a medical device and promote acceptance in the body.
Horizon Discovery is an international life science company that supplies products, services and research programs to enable a better understanding of the genetic basis of human disease and the development of targeted personalized medicines.
ID Genomics, Inc. (IDG) is developing rapid (less than 30 minutes) diagnostic tests for antibiotic susceptibility testing. Current approaches require 2 to 3days to get to this answer directly from the specimen, while IDG is the only company with a rapid test to predict which antibiotics will be effective while a patient is present.
Impel NeuroPharma’s Pressurized Olfactory Delivery (POD) device delivers aerosolized drugs to the upper nasal cavity where they are directly transported into the brain, effectively bypassing the blood-brain barrier. The POD device enables molecules to become therapeutics that were previously unable to cross the blood-brain barrier, and often allows less drug volume to be utilized, lowering plasma exposure and reducing systemic side effects.
JointMetrix Medical is pioneering the use of remote monitoring in orthopaedics by developing a body-worn sensor, a smartphone app, and a clinician report that together comprise a system used to remotely monitor patients before and after joint surgery. Their initial product, a knee monitoring system, is currently in use at UW Medical Center.
KitoTech Medical has developed revolutionary proprietary technology for closing wounds with KitoStitch. KitoStitch works for deep wounds like sutures, is fast like staples, painless like a Steri-Strip and easy to use as a Band-Aid.
Kona Medical has developed an ultrasound-based platform which enables non-invasive imaging, targeting, tracking, and treatment of soft tissue structures throughout the body without radiation and without the cost of complexity of Magnetic Resonance and other technologies.
Lamprogen focuses on taking its key competency in developing polymeric nanoparticles and microfluidic devices for enhancing the sensitivity and robustness of currently available methods used in the life sciences, especially methods that rely on optical readouts.
LodeSpin Labs is creating the next generation of iron oxide nanoparticle tracers for medical imaging, using technology developed by the founders at the University of Washington.
LumiSands offers a cost-effective, non-toxic, and eco-friendly option for REE-phosphors with our patent-pending silicon quantum dot phosphor (SiQD-phosphor) technology.
Magic Leap is working on head-mounted devices which superimpose 3D computer-generated imagery over real world objects, by projecting a digital light field into the user's eye.
Marine Construction Technologies has developed technology that reduces noise from impact pile driving, thereby protecting marine mammals and other sensitive wildlife while improving the efficiency of marine construction projects.